Antibacterial Spirotetronate Polyketides from an Actinomadura sp. Strain A30804.
Kuan-Chieh ChingElaine J ChinMario WibowoZann Y TanLay-Kien YangDeborah C SeowChung-Yan LeongVeronica W NgSiew-Bee NgYoganathan KanagasundaramPublished in: Molecules (Basel, Switzerland) (2022)
Large scale cultivation and chemical investigation of an extract obtained from Actimonadura sp. resulted in the identification of six previously undescribed spirotetronates (pyrrolosporin B and decatromicins C-G; 7 - 12 ), along with six known congeners, namely decatromicins A-B ( 1 - 2 ), BE-45722B-D ( 3 - 5 ), and pyrrolosporin A ( 6 ). The chemical structures of compounds 1 - 12 were characterized via comparison with previously reported data and analysis of 1D/2D NMR and MS data. The structures of all new compounds were highly related to the spirotetronate type compounds, decatromicin and pyrrolosporin, with variations in the substituents on the pyrrole and aglycone moieties. All compounds were evaluated for antibacterial activity against the Gram-negative bacteria, Acinetobacter baumannii and Gram-positive bacteria, Staphylococcus aureus and were investigated for their cytotoxicity against the human cancer cell line A549. Of these, decatromicin B ( 2 ), BE-45722B ( 3 ), and pyrrolosporin B ( 7 ) exhibited potent antibacterial activities against both Gram-positive (MIC 90 between 1-3 μM) and Gram-negative bacteria (MIC 90 values ranging from 12-36 μM) with weak or no cytotoxic activity against A549 cells.
Keyphrases
- acinetobacter baumannii
- multidrug resistant
- staphylococcus aureus
- gram negative
- high resolution
- drug resistant
- anti inflammatory
- pseudomonas aeruginosa
- silver nanoparticles
- electronic health record
- induced apoptosis
- oxidative stress
- mass spectrometry
- big data
- magnetic resonance
- ms ms
- squamous cell carcinoma
- biofilm formation
- machine learning
- young adults
- signaling pathway
- cell cycle arrest
- endoplasmic reticulum stress
- data analysis
- cystic fibrosis
- cell proliferation
- childhood cancer
- candida albicans